A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab

Clinical trial NCT07532213 · RECRUITING

Trial details

NCT number: NCT07532213
Sponsor: Janssen-Cilag A.G., Switzerland
Status: RECRUITING
Study type: OBSERVATIONAL

Inflammatory Bowel Disease Colitis, Ulcerative Crohn Disease

Start date: 2026-04-13
Primary completion: 2029-04-10
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.